Phibro Animal Health (PAHC) Misses Q2 EPS by 2c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Nokia shares fall despite earnings beat on cash flow concerns
Phibro Animal Health Corporation Reports Third Quarter Results, Provides Revised Financial Guidance
May 4, 2022 4:25 PM EDTTEANECK, N.J.--(BUSINESS WIRE)-- Phibro Animal Health Corporation (Nasdaq: PAHC) today announced financial results for its third quarter ended March 31, 2022.
Highlights for the three months ended March 31, 2022 (compared to the three months ended March 31, 2021) Net sales of $239.6 million, an increase of $27.9 million, or 13% Net income of $17.7 million, an increase of $5.5 million, or 45% Diluted EPS of $0.44, an increase of $0.14 or 47% Adjusted EBITDA of $28.0 million, comparable to the prior year Adjusted Net Income of $13.4 million, a decrease of $0.5 million, or... More


